Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.
We'd appreciate your feedback.Tell us what you think! opens in new tab/window
Regulators around the world recognize Embase as a source for medical literature. Life science experts rely on Embase to find relevant and current results based on Emtree indexing of full-text content and dedicated search terms.
Fast access to biological relationships and pathways to understand disease biology and get targeted data
The risk assessment tool for translational safety, drug efficacy and DMPK
Expertly curated chemical data and insights for better decision making
Elsevier's premiere platform of peer-reviewed scholarly literature
Embase guides you in using the PICO method in a search. And you can quickly formulate an advanced query to explore deeply indexed content. Your results feed into a strong systematic review that helps you to:
Access relevant information from trusted sources
Confidently publish original research
Tap into a multitude of topics and deeply connected records, including conference abstracts and clinical trials
Embase empowers your pharmacovigilance search strategy for high-recall, high-precision drug safety monitoring.
Use smart tools to ensure you don’t miss important information for compliant pharmacovigilance
Track drug-disease relations and drug-drug interactions
Recognized by regulatory bodies as a source for discovering adverse events
The European Commission references Embase as a literature source in meeting the stricter requirements of the MDR and IVDR.
Capture mentions of medical devices with dedicated device terms, subheadings and synonym suggestions from Emtree
Collect data for clinical evaluations, as well as post-market surveillance
Quickly create precise and high-recall queries
Unlimited access for organizations
For government, institutions, corporate agencies, contract research organizations and consultancies
One user gets 30-day access to Embase.com (limited to four per year). Includes five email alerts.
For individuals, small and medium size businesses. Excludes contract research organizations and consultancies.
One user gets seven-day access to Embase.com (limited to four per year).
For individuals, small and medium size businesses. Excludes contract research organizations and consultancies.
"Performing a systematic search of peer-reviewed and gray literature using Embase is generally accepted as a best practice for evidence-based medicine."
GRK
George R. Khachatryan
RosMedEx
Embase is recommended and/or referenced by:
EMA - Guideline on Good Pharmacovigilance Practices (GVP)
European Union Medical Device Regulation (EU MDR)
Cochrane Handbook for Systematic Reviews of Interventions, Version 6.2
China’s NMPA Guideline for the Collection and Reporting of Adverse Drug Reactions
WHO Handbook for Guideline Development
UK's NICE Interim Clinical Guideline Surveillance Process and Methods Guide
JBI Manuals for Evidence Synthesis and Evidence Implementation
Brazilian Ministry of Health
Therapeutic Goods Administration (TGA) Australia for Pharmacovigilance
European Network for Health Technology Assessment
Canada’s Drug Agency (CDA-AMC)
Embase has:
99% of journals in MEDLINE plus more than 3,000 additional journals
More than 99,000 preferred terms, including MeSH terms
More than 16,000 conferences
525,755 synonyms, ~495,182 more than MeSH
Granular indexing for devices and drugs
